Raymond James & Associates’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-101,550
Closed -$823K 4043
2021
Q1
$823K Buy
+101,550
New +$823K ﹤0.01% 2631